N-(Azido-PEG3)-N-bis(PEG1-t-butyl ester)
Code | Size | Price |
---|
TAR-T16185-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T16185-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N-(Azido-PEG3)-N-bis(PEG1-t-butyl ester) is a polyethylene glycol (PEG)-based PROTAC linker utilized for the synthesis of PROTACs[1].
CAS:
2086689-00-9
Formula:
C26H48N4O10
Molecular Weight:
576.68
Purity:
0.98
SMILES:
[N-]=[N+]=NCCOCCOCCOCCC(=O)NC(COCCC(=O)OC(C)(C)C)COCCC(=O)OC(C)(C)C
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562